EVELYN PILLOR: Open Payments
NPI 1568574713 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,595 in 8 payments from 5 companies in 2025. Trend: 2023 $146 · 2024 $352 · 2025 $1,595
Consulting: $940Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $1,110 |
| Enterra Medical, Inc. | 1 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $98 |
| Aimmune Therapeutics, Inc. | 1 | $56 |
Products named: Livdelzi, XIFAXAN, VOQUEZNA, VOWST.
Industry payments across CA — which companies pay providers there.
